Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish

Cancer Research

Volumn 64, Issue 20, 2004, Pages 7256-7262

  Hong, Wei Yang ^a   Kutok, Jeffery L ^b   Nam, Hyuk Lee ^a   Hui, Ying Piao ^a   Fletcher, Christopher D M ^b   Kanki, John P ^a   Look, A Thomas ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MESSENGER RNA;

ABDOMINAL TUMOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GRANULE; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; EMBRYO; EXOCRINE CELL; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NEUROENDOCRINE TUMOR; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; ONCOGENE MYCN; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS ISLET CELL; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC ANIMAL; TRANSMISSION ELECTRON MICROSCOPY; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARCINOMA, ISLET CELL; HUMANS; INSULIN; ISLETS OF LANGERHANS; NEUROECTODERMAL TUMORS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PANCREATIC NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSGENES; ZEBRAFISH;

EID: 5644221402     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0931     Document Type: Article

References (44)

1. Driever W, Solnica-Krezel L, Schier AF, et al. A genetic screen for mutations affecting embryogenesis in zebrafish. Development (Camb) 1996;123:37-46.
2. Haffter P, Granato M, Brand M, et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development (Camb) 1996;123:1-36.
3. Peterson RT, Link BA, Dowling JE, Schreiber SL. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci USA 2000;97:12965-9.
4. Peterson RT, Mably JD, Chen JN, Fishman MC. Convergence of distinct pathways to heart patterning revealed by the small molecule concentramide and the mutation heart-and-soul. Curr Biol 2001;11:1481-91.
5. Amatruda JF, Shepard JL, Stern HM, Zon LI. Zebrafish as a cancer model system. Cancer Cell 2002;1:229-31.
6. Langenau DM, Traver D, Ferrando AA, et al. Myc-induced T cell leukemia in transgenic zebrafish. Science (Wash DC) 2003;299:887-90.
7. Inohara N, Nunez G. Genes with homology to mammalian apoptosis regulators identified in zebrafish. Cell Death Differ 2000;7:509-10.
8. Langenau DM, Palomero T, Kanki JP, et al. Molecular cloning and developmental expression of T1x (Hox11) genes in zebrafish (Danio rerio). Mech Dev 2002;117: 243-8.
9. Liu TX, Zhou Y, Kanki JP, et al. Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies. Proc Natl Acad Sci USA 2002;99:6136-41.
10. Kalev-Zylinska ML, Horsfield JA, Flores MV, et al. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development (Camb) 2002;129: 2015-30.
11. Smolowitz R, Hanley J, Richmond H. A three-year retrospective study of abdominal tumors in zebrafish maintained in an aquatic laboratory animal facility. Biol Bull 2002;203:265-6.
12. Walker WW, Manning CS, Overstreet RM, Hawkins WE. Development of aquarium fish models for environmental carcinogenesis: an intermittent-flow exposure system for volatile, hydrophobic chemicals. J Appl Toxicol 1985;5:255-60.
13. Spitsbergen JM, Tsai HW, Reddy A, et al. Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N′-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol Pathol 2000;28:716-25.
14. Spitsbergen JM, Tsai HW, Reddy A, et al. Neoplasia in zebrafish (Danio rerio) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages. Toxicol Pathol 2000;28:705-15.
15. Rubinstein AL. Zebrafish: from disease modeling to drug discovery. Curr Opin Drug Discov Devel 2003;6:218-23.
16. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999;18:3004-16.
17. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Wash DC) 1984;224:1121-4.
18. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6.
19. Wong AJ, Ruppert JM, Eggleston J, et al. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science (Wash DC) 1986;233:461-4.
20. Garson JA, McIntyre PG, Kemshead JT. N-myc amplification in malignant astrocytoma. Lancet 1985;2:718-9.
21. Garson JA, Clayton J, McIntyre P, Kemshead JT. N-myc oncogene amplification in rhabdomyosarcoma at release. Lancet 1986;1:1496.
22. Garson JA, Pemberton LF, Sheppard PW, et al. N-myc gene expression and oncoprotein characterisation in medulloblastoma. Br J Cancer 1989;59:889-94.
23. Lee WH, Murphree AL, Benedict WF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature (Lond) 1984;309:458-60.
24. Goldhamer DJ, Faerman A, Shani M, Emerson CP Jr. Regulatory elements that control the lineage-specific expression of myoD. Science (Wash DC) 1992;256: 538-42.
25. Westerfield M, Doerry E, Kirkpatrick AE, Driever W, Douglas SA. An on-line database for zebrafish development and genetics research. Semin Cell Dev Biol 1997;8:477-88.
26. Bennett CM, Kanki JP, Rhodes J, et al. Myelopoiesis in the zebrafish, Danio rerio. Blood 2001;98:643-51.
27. Goldhamer DJ, Brunk BP, Faerman A, et al. Embryonic activation of the myoD gene is regulated by a highly conserved distal control element Development (Camb) 1995;121:637-49.
28. Kucharczuk KL, Love CM, Dougherty NM, Goldhamer DJ. Fine-scale transgenic mapping of the MyoD core enhancer: MyoD is regulated by distinct but overlapping mechanisms in myotomal and non-myotomal muscle lineages. Development (Camb) 1999;126:1957-65.
29. Tomita T. New markers for pancreatic islets and islet cell tumors. Pathol Int 2002; 52:425-32.
30. Redecker P, Grube D. [Synaptophysin in the nervous system and endocrine cells]. Acta Histochem Suppl 1992;42:33-8.
31. Hartroft WS, Wrenshall GA. Correlation of beta-cell granulation with extractable insulin of the pancreas; studies in adult human diabetics and nondiabetics. Diabetes 1955;4:1-7.
32. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 2003;284:E671-8.
33. O'Connor DT, Deftos LJ. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 1986;314:1145-51.
34. Reichlin S. Secretion of somatostatin and its physiologic function. J Lab Clin Med 1987;109:320-6.
35. Wick MR, Graeme-Cook FM. Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information. Am J Clin Pathol 2001;115(Suppl):S28-45.
36. Pavelic K, Hrascan R, Kapitanovic S, et al. Molecular genetics of malignant insulinoma. Anticancer Res 1996;16:1707-17.
37. Pavelic K, Hrascan R, Kapitanovic S, et al. Multiple genetic alterations in malignant metastatic insulinomas. J Pathol 1995;177:395-400.
38. Pelengaris S, Khan M. Oncogenic co-operation in beta-cell tumorigenesis. Endocr Relat Cancer 2001;8:307-14.
39. Aubry S, Charron J. N-Myc shares cellular functions wiht c-Myc. DNA Cell Biol 2000;19:353-64.
40. Mukherjee B, Morgenbesser SD, DePinho RA. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev 1992;6:1480-92.
41. Malynn BA, de Alboran IM, O'Hagan RC, et al. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 2000;14:1390-9.
42. Pelengaris S, Khan M, Evan GI. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 2002;109:321-34.
43. Lewis BC, Klimstra DS, Varmus HE. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. Genes Dev 2003;17:3127-38.
44. Toffolatti L, Frascella E, Ninfo V, et al. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples. J Pathol 2002;196:450-8.